Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 9428
TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM50357312(IBRUTINIB | US9181263, 1 | US9108973, Ref 1 | US92...)
Affinity DataIC50: 1.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465837(US10793576, Example 69)
Affinity DataIC50: 1.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465786(US10793576, Example 18)
Affinity DataIC50: 1.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465822(US10793576, Example 54)
Affinity DataIC50: 1.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465821(US10793576, Example 53)
Affinity DataIC50: 1.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465816(US10793576, Example 48)
Affinity DataIC50: 2.10nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465823(US10793576, Example 55)
Affinity DataIC50: 2.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465838(US10793576, Example 70)
Affinity DataIC50: 2.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465820(US10793576, Example 52)
Affinity DataIC50: 2.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465779(US10793576, Example 11)
Affinity DataIC50: 2.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465777(US10793576, Example 9)
Affinity DataIC50: 2.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465865(US10793576, Example 97)
Affinity DataIC50: 2.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465864(US10793576, Example 96)
Affinity DataIC50: 3.10nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465790(US10793576, Example 22 | 4-(3-((1R,3S,4S)-2-acrylo...)
Affinity DataIC50: 3.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465781(US10793576, Example 13)
Affinity DataIC50: 3.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465861(US10793576, Example 93 | Preparation of (S)-1-(6-(...)
Affinity DataIC50: 3.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465814(US10793576, Example 46)
Affinity DataIC50: 4.20nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465824(US10793576, Example 56)
Affinity DataIC50: 4.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465860(US10793576, Example 92)
Affinity DataIC50: 4.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465894(US10793576, Example 126 | Preparation of (1 S,4S)-...)
Affinity DataIC50: 4.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465811(US10793576, Example 43)
Affinity DataIC50: 4.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465772(US10793576, Example 4)
Affinity DataIC50: 4.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465872(US10793576, Example 104)
Affinity DataIC50: 4.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465881(US10793576, Example 113 | Preparation of 4-(8-amin...)
Affinity DataIC50: 4.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465771(US10793576, Example 3)
Affinity DataIC50: 4.70nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465817(US10793576, Example 49)
Affinity DataIC50: 4.80nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465847(US10793576, Example 79)
Affinity DataIC50: 4.90nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465815(US10793576, Example 47)
Affinity DataIC50: 5.20nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465836(US10793576, Example 68)
Affinity DataIC50: 5.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465810(US10793576, Example 42)
Affinity DataIC50: 5.30nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465886(US10793576, Example 118 | Preparation of 4-(3-((1R...)
Affinity DataIC50: 5.60nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465862(US10793576, Example 95 | US10793576, Example 94)
Affinity DataIC50: 7.20nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465845(US10793576, Example 77)
Affinity DataIC50: 8.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465774(US10793576, Example 6)
Affinity DataIC50: 9.10nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465853(US10793576, Example 85)
Affinity DataIC50: 9.40nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465784(US10793576, Example 16)
Affinity DataIC50: 9.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465839(US10793576, Example 71)
Affinity DataIC50: 12nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465782(US10793576, Example 14)
Affinity DataIC50: 12.5nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465830(US10793576, Example 62)
Affinity DataIC50: 13nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465857(US10793576, Example 91 | US10793576, Example 89)
Affinity DataIC50: 14nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465780(US10793576, Example 12)
Affinity DataIC50: 14nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465862(US10793576, Example 95 | US10793576, Example 94)
Affinity DataIC50: 14.3nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465852(US10793576, Example 84)
Affinity DataIC50: 16.3nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465813(US10793576, Example 45)
Affinity DataIC50: 17nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465783(US10793576, Example 15)
Affinity DataIC50: 17.4nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465841(US10793576, Example 73)
Affinity DataIC50: 18nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465873(US10793576, Example 105)
Affinity DataIC50: 18nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465892(US10793576, Example 124 | Preparation of (S)-3-(3-...)
Affinity DataIC50: 18nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465846(US10793576, Example 78)
Affinity DataIC50: 18.4nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chengdu Brilliant Pharmaceutical

US Patent
LigandPNGBDBM465877(US10793576, Example 109)
Affinity DataIC50: 19nMAssay Description:1: Test Principle:Mobility-Shift Assay, which is microfluidic chip technology, applies the basic concept of capillary electrophoresis to microfluidic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: